New Novartis vaccine guards mice against E. coli

After mapping the gene for the E. coli bacterium, researchers for Novartis believe that they have found the key elements needed to create a vaccine that can protect people from all the bacterial infections that E. coli can cause.

The mapping program successfully guided scientists to nine antigens that protected mice from E. coli. Certain strains of the bacteria in meat and produce can cause a violent physical reaction in people ranging from blood poisoning to neonatal meningitis.

"We know that we have the potential there, and this could mean that once you get vaccinated you could even be covered against all the different diseases that E. coli can cause," Novartis researcher Mariagrazia Pizza told Reuters. "The development of such a vaccine will be very challenging for the company, but if we were successful at the end, obviously it would be a big thing."

- here's the story from Red Orbit
-
see the Reuters article

Suggested Articles

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.

Takeda has spent considerable resources on its phase 3 dengue vaccine, and now data show the shot was 80% effective in preventing dengue.